Last A$1.02 AUD
Change Today 0.00 / 0.00%
Volume 230.0K
VSC On Other Exchanges
Symbol
Exchange
Frankfurt
As of 1:54 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

vita life sciences ltd (VSC) Snapshot

Open
A$1.02
Previous Close
A$1.02
Day High
A$1.02
Day Low
A$1.02
52 Week High
04/2/13 - A$1.50
52 Week Low
05/21/12 - A$0.33
Market Cap
57.6M
Average Volume 10 Days
91.3K
EPS TTM
A$0.04
Shares Outstanding
56.4M
EX-Date
03/8/13
P/E TM
24.1x
Dividend
A$0.01
Dividend Yield
1.40%
Current Stock Chart for VITA LIFE SCIENCES LTD (VSC)

Related News

No related news articles were found.

vita life sciences ltd (VSC) Related Businessweek News

No Related Businessweek News Found

vita life sciences ltd (VSC) Details

Vita Life Sciences Limited engages in formulating, packaging, selling, and distributing vitamins and supplements primarily in Australia, Singapore, and Malaysia. It offers a range of supplements, vitamins, minerals, meal replacement, sports nutrition, and herbals for men, women, and children; and over the counter products. The company markets its products through pharmacies and health food stores primarily under the VitaHealth and Herbs of Gold brand names. Vita Life Sciences Limited was founded in 1947 and is headquartered in Melbourne, Australia.

350 Employees
Last Reported Date: 03/26/13
Founded in 1947

vita life sciences ltd (VSC) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: A$124.3K
President of Multi-Level Marketing
Total Annual Compensation: A$150.6K
Senior General Manager of Asian Business and ...
Total Annual Compensation: A$185.6K
Compensation as of Fiscal Year 2012.

vita life sciences ltd (VSC) Key Developments

Vita Life Sciences Limited Reports Earnings Results for the Year Ended December 31, 2012; Declares Final Dividend, Payable on March 28, 2013; Provides Earnings Guidance for the Fiscal Year 2013

Vita Life Sciences Limited reported earnings results for the year ended December 31, 2012. For the year, the company's revenue was $30.191 million compared with $24.267 million a year ago. EBIT was $2.865 million compared with $1.489 million a year ago. Profit before tax was $2.841 million compared with $1.403 million a year ago. Profit after tax was $2.316 million or 4.14 cents per share compared with $1.213 million or 2.12 cents per share a year ago. EBITDA was $2.87 million compared with $1.49 million a year ago. Operating cash flows were $1.38 million compared with $5.66 million a year ago. The company declared final dividend of 0.5 cent per share for the year ended December 31, 2012. Total dividend for the financial year was 1.0 cent per share. The dividend will be payable on March 28, 2013 to the shareholders of record on March 15, 2013. The ex-dividend date is March 8, 2013. Barring unforeseen circumstances, the company is targeting a 40% to 50% increase in EBIT in the fiscal year 2013.

Vita Life Sciences Limited to Report Fiscal Year 2012 Results on Feb 28, 2013

Vita Life Sciences Limited announced that they will report fiscal year 2012 results on Feb 28, 2013

Vita Life Sciences Limited Provides Group Earnings Guidance for the Second Half and Full Year Ending December 2012; Provides Final Dividend Guidance

Vita Life Sciences Limited provided group earnings guidance for the second half and full year ending December 2012. For the period, the group expects revenue to continue its momentum with growth in the second half of the year being similar to the first half. NPAT for the second half is anticipated to be similar to the first half. Based on the group's management accounts to October and its forecast for November and December 2012: Sales revenue is forecast to be $29.0 million to $30.0 million, or approximately 20% higher than the year to December 31, 2011. Profit before tax to be approximately 18% - 20% higher than that reported for the six months to June 2012. For the year, the company expects profit before tax to be approximately $2.3 million, or 65% higher than the year to December 2011. The company’s Directors expect to declare a fully franked final dividend of 0.5 cent per share payable in April 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSC:AU A$1.02 AUD 0.00

VSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VSC.
View Industry Companies
 

Industry Analysis

VSC

Industry Average

Valuation VSC Industry Range
Price/Earnings 23.3x
Price/Sales 1.7x
Price/Book 4.8x
Price/Cash Flow 23.0x
TEV/Sales 1.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITA LIFE SCIENCES LTD, please visit www.vitalifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.